| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.49B | -13.3% |
| Cost of Revenue | $1.38B | -12.2% |
| Gross Profit | $104.4M | -25.6% |
| R&D Expense | $17.5M | -4.4% |
| SG&A Expense | $50.3M | -24.5% |
| Operating Income | $45.5M | -7.6% |
| Interest Expense | $14.7M | -35.4% |
| Pre-tax Income | $26.2M | +4.1% |
| Income Tax | $9.2M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.8M | +13.9% |
| Accounts Receivable | $222.6M | -21.1% |
| Inventory | $273.5M | -19.1% |
| Current Assets | $699.6M | -17.4% |
| Total Assets | $1.08B | -10.8% |
| Current Liabilities | $318.6M | -15.1% |
| Long-term Debt | $147.1M | -50.1% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $183.9M | +151.2% |
| Capital Expenditures | $33.3M | -27.8% |
| Investing Cash Flow | -$14.7M | +68.4% |
| Financing Cash Flow | -$160.9M | -1892.7% |
| Free Cash Flow | $150.7M | +455.1% |
| +97.2% |
| Net Income | $17.0M | -17.2% |
| EPS (Basic) | $0.68 | -17.1% |
| EPS (Diluted) | $0.68 | -16.0% |
| Stockholders' Equity |
| $569.9M |
| +5.4% |